Merck KGaA (FRA:MRK) has been given a €110.00 ($130.95) price objective by equities research analysts at Bank of America Corporation in a report issued on Wednesday. The firm presently has a “buy” rating on the healthcare company’s stock.

MRK has been the subject of several other reports. HSBC Holdings plc set a €94.00 ($111.90) target price on Merck KGaA and gave the stock a “neutral” rating in a research note on Wednesday, August 9th. S&P Global set a €115.00 ($136.90) target price on Merck KGaA and gave the stock a “neutral” rating in a research note on Friday, May 19th. Warburg Research set a €116.00 ($138.10) target price on Merck KGaA and gave the stock a “neutral” rating in a research note on Tuesday, June 20th. Deutsche Bank AG set a €106.00 ($126.19) target price on Merck KGaA and gave the stock a “neutral” rating in a research note on Wednesday, July 26th. Finally, Nord/LB set a €100.00 ($119.05) target price on Merck KGaA and gave the stock a “neutral” rating in a research note on Thursday, August 3rd. Fourteen research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of €107.71 ($128.23).

Shares of Merck KGaA (FRA MRK) traded up 0.022% during midday trading on Wednesday, hitting €95.623. The company had a trading volume of 1,786 shares. The firm has a market capitalization of €41.57 billion and a PE ratio of 24.928. The company has a 50-day moving average of €93.50 and a 200 day moving average of €102.64. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00.

WARNING: This piece was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/09/10/merck-kgaa-mrk-pt-set-at-110-00-by-bank-of-america-corporation.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.